EMA Withdrawn: Vivanza (vardenafil) — Bayer AG

View source ↗

Summary

EMA has withdrawn Vivanza (vardenafil) from the market (Bayer AG) for erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Vivanza (vardenafil)

Snippet

Status: Withdrawn. Therapeutic area: Erectile Dysfunction. MAH: Bayer AG. Decision date: 20/10/2021